ArticleRadiological physics and technology2026
Comparison of small bowel and bladder doses between prone and supine positions in preoperative intensity-modulated radiotherapy for rectal cancer.
Article in Radiological physics and technology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Evidence supporting the benefit of the prone position (PP) over the supine position (SP) in preoperative intensity-modulated radiotherapy (IMRT) for locally advanced rectal cancer remains limited. Furthermore, criteria available at simulation for selecting patients likely to benefit from PP are lacking. This study assessed the dosimetric impact of PP versus SP on the small bowel and bladder and explored factors associated with PP-related dose sparing to identify patients likely to benefit. We retrospectively analyzed simulation CT scans in both PP and SP from consecutive rectal cancer patients treated with preoperative radiotherapy (July 2019–April 2024). Paired IMRT plans were created for each position, and dose-volume parameters for the small bowel and bladder were compared using the Wilcoxon signed-rank test. Predictors of small bowel dose reduction were assessed using univariable and multivariable regression analyses, including a novel indicator, the ratio of abdominal protrusion, defined as the protrusion at the sacral promontory level in SP divided by that in PP. Among 24 patients, mean small bowel V40Gy was lower in PP (56.2 vs. 72.6 cm3, p = 0.03) and mean bladder V25Gy–V50Gy were consistently lower in PP (all p < 0.01). A lower ratio of abdominal protrusion was associated with greater small bowel V40Gy reduction in univariable and multivariable analyses (p = 0.01 in each). PP reduced high-dose small bowel exposure and mid- to high-dose bladder exposure. CT simulation in both positions to calculate the abdominal protrusion ratio may guide individualized positioning.
Indexed as
Identifiers
42008045What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.